NA Proactive news snapshot: American Battery Metals, Co-Diagnostics, BioLargo, Mota Ventures UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Newspapers and laptop
Your daily round-up from the world of Proactive

American Battery Metals Corporation (OTCMKTS:ABML), an advanced extraction and battery recycling technology company, said Monday the coronavirus (COVID-19) outbreak has “wreaked havoc” on battery metals supply chains that are dominated by China. The Nevada-based company said the COVID-19 pandemic arose just as the battery metals markets, particularly lithium, “started to see signs of a pricing rebound in the first quarter of 2020.” American Battery Metals said the big three lithium companies have telegraphed profit warnings due to coronavirus-driven logistics issues in the supply chain, highlighting just how reliant the US is on China for the critical minerals necessary for electric vehicles and stationary storage applications.

Broker HC Wainwright has repeated a 'Buy' on Co-Diagnostics Inc (NASDAQ:CODX) after the new FDA policy reported last week, which allows the company to aggressively expand its coronavirus test kits in the US. The broker has a $20 price target on the stock, which is more than double where they stand today at around $9.60. Analyst Yi Chen noted that the biotech can now market its Logix Smart coronavirus (COVID-19) test to a "wide array" of US laboratories without first requiring Emergency Use Authorization (EUA) from the FDA.

BioLargo Inc (OTCMKTS:BLGO) CEO Dennis P Calvert said Monday that the company is "forging ahead" and is uniquely positioned to 'weather the storm' of the coronavirus (COVID-19) outbreak as it outlined its response to the pandemic. The firm's major clients are municipalities, landfills and air force bases and it continues to support them, said Calvert. For example, the Canadian team at BioLargo Water is formulating a proprietary product using core technology in response to a Canadian government request for hand sanitizers.

Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) said Monday that it is launching an immune support CBD line inspired by the traction it is getting from the March 14 launch of its Pure Herbal Immunity Blend, which is marketed under its First Class brand. In a statement, the Vancouver-based company said its all-natural Immunity Blend snapped up 1,838 new customers within a week. The formulation includes 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano, the company said.

BioPorto A/S (CPH:BIOPOR) (NASDAQOMX:BIOPOR) said it will convene its annual general meeting on April 14, at 3 pm (CET) at Tuborg Havnevej 15, DK-2900 Hellerup. The meeting will focus on the Danish in-vitro diagnostic company’s activities during the past year, presentation of its annual report, approval of renumeration for the company’s board of directors. The AGM’s agenda will include efforts to re-elect Thomas Magnussen, Torben Arnth Nielsen, Christopher Lindop, Kirsten Aarup Drejer and Michael S. Singer to the board

Medexus Pharmaceuticals Inc (CVE:MDP) (OTCMKTS:PDDPF) will present at the upcoming 2020 Spring Investor Summit held March 25th-26th.. Due to the coronavirus (COVID-19), the conference will be hosted virtually, rather than in New York. CEO Ken d’Entremont and CFO Roland Boivin are scheduled to present at 3:05 pm ET on March 25th. One-on-one meetings will be held throughout the event via conference calls. The presentation will be webcast live here. The summit is expected to draw more than 500 registered executives and investors.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) says CEO Dr Seth Lederman will conduct a virtual presentation in conjunction with the Spring Investor Summit on March 25, at 1:50 pm ET. A live webcast and subsequent archived recording of the company’s virtual presentation will be available under the IR events tab of the investor relations section of the Tonix website at www.tonixpharma.com. Tonix is developing an array of pharmaceutical products that take aim at neuropsychiatric conditions.

Duos Technologies Group Inc (NASDAQ:DUO), a provider of intelligent security analytical technology solutions, will hold a conference call March 30 at 4:30 pm Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2019. Financial results will be issued via press release prior to the call. Management will host the conference call, followed by a question and answer period. US dial-in: 877-407-3088; International dial-in: +1 201-389-0927; Confirmation: 13700827.

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Monday that its Jet-Oxide 15% sanitizer product has been approved by the US Environmental Protection Agency for use on industrial food and agricultural hard surfaces against the coronavirus (COVID-19). The EPA conducted a study with Human Coronavirus Strain 229E, a different, more common coronavirus strain associated with human colds, found that Jet-Oxide produced a 99.99% reduction of the strain. Jet-Oxide can be used to treat unprocessed fruits and vegetables, as well as any surfaces, equipment or machinery that produce comes in contact with.

eWellness Healthcare Corporation (OTCMKTS:EWLL) said it has trained 188 physical therapists (PTs) on its PHIZIO telehealth platform over the past 15 days as patients flock to telemedicine amid the coronavirus (COVID-19) pandemic.Of the newly-trained PTs, 97 are located in 17 US states and the other 91 are located in 7 Candian provinces. The group said these additional trained PT’s at full capacity can complete 15,000 patient visits per year, which is equal to 2.8 million PT visits annually.

Surge Holdings Inc (OTCMKTS:SURG) CEO Brian Cox released a letter to shareholders on Monday, assuring them that the company remains at full capacity and well-positioned in the long term despite the coronavirus pandemic. “During these unprecedented times I’d like to reassure our customers and shareholders that our business has been uninterrupted,” Cox wrote. “We believe our business is very well positioned for the long-term in any market environment,” Cox wrote. “Specifically, we believe our broad offering for the unbanked and underbanked, as well as free and no-contract wireless services are especially attractive during periods of economic uncertainty."

Next Green Wave Holdings Inc (CSE:NGW) (OTCMKTS:NXGWF) said Monday that its facility in Fresno County, California continues to operate at full capacity amid the coronavirus outbreak. Under the county’s Shelter In Place guidelines, the company’s cannabis cultivation and distribution facility is deemed to be an essential service given the plant’s medicinal and therapeutic properties. Next Green Wave noted that it has begun taking additional precautions to ensure the safety and health of its employees and partners amid the COVID-19 pandemic.

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) announced a series of steps Monday designed to mitigate the impact of the coronavirus pandemic on its Canadian operations. The Toronto-based medical cannabis company said it was scaling back cultivation operations in Cobourg, Ontario in line with guidance from the provincial and local health officials. “Following a COVID-19 Declaration of Emergency by the Government of Ontario and confirmation of the presence of coronavirus infections in the town of Cobourg with nearly 19,000 residents, we have taken necessary steps to ensure the safety of FV Pharma’s employees, the Cobourg community and our in-facility partners," said Raza Bokhari, FSD’s CEO.

GlobeX Data Ltd (OTCMKTS:SWISF) announced Monday that it has received a dramatic influx in demand for its Swiss-hosted cybersecurity solutions as more and more people work remotely in response to the coronavirus (COVID-19). When employees work from home, they often rely on unsecured internet connections, creating a need for companies to protect their communications. In the US, GlobeX is preparing for mass demand by putting partnerships in place with its main reseller in the country as part of an effort to limit the damages of cyberattacks.

Aequus Pharmaceuticals Inc (CVE:AQS) (OTCMKTS:AQSZF) CEO Doug Janzen told investors that the firm has adequate funds and cash flow to operate the business amid the coronavirus outbreak. In a statement, Janzen noted that the speciality pharmaceutical company's commercial products were taken daily to help manage serious chronic conditions. He said the company continues to see prescriptions filled without interruption for both its PrVistitan (glaucoma) drug and Tacrolimus (anti-organ rejection) drug.

Genprex Inc (NASDAQ:GNPX) has appointed two experienced life sciences executives as the firm advances its lead drug candidate into key clinical programs and pursues partnerships for its cancer platform and newly licensed gene therapy technology for diabetes. Catherine M Vaczy becomes executive vice president and chief strategy officer, while Michael T Redman becomes executive vice president and chief operating officer.

KinerjaPay Corp (OTCMKTS:KPAY) on Monday said it expects to receive a bank guarantee for $25 million by March 31. In a statement, the company noted it has incurred additional costs thanks to a decision by the bank's compliance department to hike the cost of issuing the MT-799 Bank Guarantee, thus delaying the receipt. KinerjaPay said CEO Edwin Ng's recent $1 million equity infusion into the company will allow it to “handle this burden.” The company's investor, Infinity Venture Capital Pte Ltd, a Singapore-based corporation, has advised it that once these costs have been covered, the bank will issue the $25 million guarantee to its local bank. 

Ideanomics Inc (NASDAQ:IDEX) said that its subsidiary Mobile Energy Global (MEG) has struck a strategic framework agreement with leading electric vehicle (EV) truck and bus maker, BeiBen Heavy Truck Company. The fintech company said the agreement is designed to establish a long-term strategic partnership that will boost “the speed and efficiency of commercial vehicle adoption.” The agreement is preliminary and will be subject to legally binding definitive transaction documents to be negotiated between Ideanomics and BeiBen. Under the agreement, BeiBen will provide electric heavy truck manufacturing, research, sales, operations, and other resources. In return, MEG will provide its existing new energy vehicle platform including its financial services network, marketing capabilities, government relationships, and access to partners in China and Southeast Asia.

Endeavour Mining Corporation (TSE:EDV) (OTCMKTS:EDVMF) has revealed it is to combine with SEMAFO Inc (TSE:SMF) in a C$1 billion deal which will create a leading West Africa-based gold producer generating over 1 million ounces a year. The merger brings together six mines with strong cash flow into one portfolio, the opportunity to optimize assets, and a growth pipeline. Both company's boards have unanimously approved the transaction. Under the deal, each SEMAFO shareholder will receive 0.1422 Endeavour shares, representing a premium of 27.2% based on the 20-day volume-weighted average price of both companies for the period to March 20 this year.

XPhyto Therapeutics Corp (CSE:XPHY) updated investors with regards to its infectious disease program, particularly as it pertains to combating the coronavirus (COVID-19) pandemic. In a statement, XPhyto said its wholly-owned German subsidiary Vektor Pharma TF GmbH, has struck a binding standstill agreement with a European biotechnology company for developing a low-cost, real-time oral pathogen screening platform. The enzyme-based platform was designed for species-specific bacterial pathogen detection in humans and will be expanded to include viral pathogen detection capability. No training is required to operate the test, the company said.

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) told investors Monday that it has broadened the scope of its pharmaceutical subsidiary in a bid to help assist in the global fight against coronavirus. The company’s subsidiary Lexaria Pharmaceutical Corp will look at how the parent company’s DehydraTECH drug delivery platform could improve delivery and effectiveness of antiviral drugs to treat coronavirus. Kelowna, British Columbia-based Lexaria said it plans to expand collaboration with leading laboratories in North America and internationally “as soon as possible.”

Arcadia Biosciences Inc (NASDAQ:RKDA), the crop science firm, has announced a tie-up with Vivion Specialties Inc (VSI) to distribute its first Hawaiian grown and extracted ingredients throughout North America. The new partnership is between Vivion and Archipelago Ventures - the firm's joint venture with Legacy Ventures Hawaii to grow and extract high-quality hemp and derivatives on the islands.

Allot Ltd (NASDAQ:ALLT) has been chosen by semiconductor manufacturer Broadcom Inc (NASDAQ:AVGO) as the recommended vendor to provide a transition path from the discontinued line of PacketShaper network optimizing products to the Allot Secure Service Gateway. Broadcom acquired the enterprise security business of Symantec Corporation back in November, and the company opted to end PacketShaper on March 31 and concentrate its investment in the enterprise security software market. That’s where Allot comes in. Under the partnership agreement, Allot is offering attractive financial terms and discounts on products replacement to help customers transition from PacketShaper to equivalent Allot products. The terms will be offered through 2020, the company said. 

CytoDyn Inc (OTCMKTS:CYDY) announced Monday that two more coronavirus (COVID-19) patients have been treated with the company’s drug leronlimab since Thursday, bringing the number of patients treated with the drug to four. The use of leronlimab, which has other therapeutic indications as a treatment for HIV and certain breast cancers, is being administered under an emergency Investigational New Drug Application recently granted by the US Food and Drug Administration.  The new patients, like the two before them, are being treated at a leading New York City hospital, the company said.

Parallax Health Sciences Inc (OTCMKTS:PRLX) announced Monday it is accepting orders for its coronavirus Point-of-Care diagnostics kits for US medical practices, hospitals, nursing operations, emergency centers, and nursing homes.  In a statement, the company also said it is providing immediate availability and access to Personal Protection Equipment (PPE) including, but not limited to, FDA-approved medical masks, protective sterile gowns, eye-protecting goggles, face shields, ventilators, and other medical grade equipment.

Mandalay Resources Corp (TSE:MND) (OTCMKTS:MNDJF) told investors that the coronavirus pandemic has not impacted its production or supply chain so far There has been an outbreak in all the countries where Mandalay operates - Canada, Australia, Sweden and Chile - but none of its employees and contractors have been diagnosed with the virus, the group said in a statement.

mCloud Technologies Corp (CVE:MCLD) (OTCMKTS:MCLDF) announced Monday it is “evaluating alternative arrangements” with BuildingIQ (ASX:BIQ), an Australia-listed company that mCloud had been making plans to acquire.  In a statement, mCloud said it has identified “material misrepresentations” during the due diligence process.

Phunware, Inc. (NASDAQ:PHUN), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced that it has entered into a financing transaction for the issuance of a series of senior convertible notes in the aggregate original principal amount of $3 million and a maturity date of December 31, 2021 with an institutional investor. It said it will receive approximately $2.564 million in net proceeds at closing, after deducting placement agent fees, The company added that it can pay off the notes either in cash or by selling securities, while holders of the notes will have the option to convert as desired at $3.00 per share or higher subject to adjustments.

NetCents Technology Inc. (CSE:NTC) announced that, further to the management cease trade order (MCTO) issued by the British Columbia Securities Commission on March 4, 2020, in connection with a delay by the company in filing its annual financial statements before the prescribed deadline of February 28, 2019, it continues to work closely with its auditor and expects to make the required filings on or before April 15, 2020.

Ximen Mining Corp (CVE:XIM) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on March 20, 2020, which will see the issue of 454,545 shares at a purchase price of 33 cents each, together with 454,545 share purchase warrants at an exercise price of 55 cents each for a three-year period, with one placee.

Explorex Resources Inc. (CSE:EX)) (OTCMKTS:EXPXF) has announced the closing of its non-brokered financing consisting of to 2,272,900 common shares priced at $0.22 per each, as previously announced on February 3, and March 11, 2020, for aggregate gross proceeds of $500,038. The funds received will be used for general working capital and for the payment to Origen Resources Inc. under the proposed Plan of Arrangement, which received the final order from the Supreme Court of British Columbia on March 13, 2020.

Getchell Gold Corp. (CSE:GTCH) (OTCMKTS:GGLDF), a leading Nevada focused Gold and Copper exploration company, today announced that its common stock has been approved for trading on the OTCQB Venture Market under the ticker symbol "GGLDF", effective as of the opening of trading today, March 23, 2020. The company will continue to trade on the Canadian Securities Exchange under the symbol "GTCH". "It is intended that the OTCQB Venture Market will provide our current and future shareholder base with increased visibility and transparency through high-quality disclosure, transparent trading and ease of access to Company information. This is an exciting development and we are pleased to commence trading on the OTCQB", said Bill Wagener, CEO & Director of Getchell Gold.

Nuvo Pharmaceuticals Inc. (CVE:NRI) (OTCMKTS:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, said that Jesse Ledger, its president & chief executive officer and Kelly Demerino, its interim chief financial officer will present live at LifeSciencesInvestorForum.com on March 26 at 10.00am Eastern Time (ET).  The live, interactive online event, organised by part of OTC Markets Group will see investors invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. LINK: https://tinyurl.com/March26LSIF

Emmaus Life Sciences, Inc. (OTCMKTS:EMMA), a leader in sickle cell disease treatment, announced that Dr. Yutaka Niihara, its chairman and chief executive officer, and Jay Sherwood, its chief financial officer, will also present live at LifeSciencesInvestorForum.com on March 26 at 11.00am ET. LINK: https://tinyurl.com/032620LSIF

And RedHill Biopharma Ltd. (NASDAQ:RDHL), a specialty biopharmaceutical company focused on gastrointestinal diseases, said that its chief business officer, Guy Goldberg will also present a corporate overview at the virtual Life Sciences Investor Forum on Thursday, March 26, at 9:30am ET. The live broadcast and Q&A session can be accessed via the company's website, http://ir.redhillbio.com/events.

—A previous version of this story gave the incorrect date of a presentation at the Spring Investor Summit—

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Endeavour Mining Corp named herein, including the promotion by the Company of Endeavour Mining Corp in any Content on the Site, the Company...



Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

1 day, 23 hours ago

16 min read